These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Natriuretic peptides and right atrial fibrosis in patients with paroxysmal versus persistent atrial fibrillation. Cao H, Xue L, Wu Y, Ma H, Chen L, Wang X, Zhu Q, Dai N, Chen Y. Peptides; 2010 Aug; 31(8):1531-9. PubMed ID: 20434499 [Abstract] [Full Text] [Related]
25. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease. Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M. Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312 [Abstract] [Full Text] [Related]
32. B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Taylor JA, Christenson RH, Rao K, Jorge M, Gottlieb SS. Am Heart J; 2006 Dec 18; 152(6):1071-6. PubMed ID: 17161055 [Abstract] [Full Text] [Related]
33. [Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI]. Alibay Y, Schmitt C, Beauchet A, Dubourg O, Alexandre JA, Boileau C, Jondeau G, Puy H. Ann Biol Clin (Paris); 2005 Dec 18; 63(1):43-9. PubMed ID: 15689311 [Abstract] [Full Text] [Related]
35. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress. Bal L, Thierry S, Brocas E, Van de Louw A, Pottecher J, Hours S, Moreau MH, Perrin Gachadoat D, Tenaillon A. Acta Anaesthesiol Scand; 2006 Mar 18; 50(3):340-7. PubMed ID: 16480468 [Abstract] [Full Text] [Related]